<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101573691</journal-id>
<journal-id journal-id-type="pubmed-jr-id">39703</journal-id>
<journal-id journal-id-type="nlm-ta">Cell Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Rep</journal-id>
<journal-title-group>
<journal-title>Cell reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2211-1247</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32553165</article-id>
<article-id pub-id-type="pmc">7401321</article-id>
<article-id pub-id-type="doi">10.1016/j.celrep.2020.107770</article-id>
<article-id pub-id-type="manuscript">NIHMS1604808</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Identification of a G-Protein-Independent Activator of GIRK Channels</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Yulin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ung</surname>
<given-names>Peter Man-Un</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zahoránszky-Kőhalmi</surname>
<given-names>Gergely</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zakharov</surname>
<given-names>Alexey V.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martinez</surname>
<given-names>Natalia J.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simeonov</surname>
<given-names>Anton</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Glaaser</surname>
<given-names>Ian W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rai</surname>
<given-names>Ganesha</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schlessinger</surname>
<given-names>Avner</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marugan</surname>
<given-names>Juan J.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Slesinger</surname>
<given-names>Paul A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA</aff>
<aff id="A2"><label>2</label>Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA</aff>
<aff id="A3"><label>3</label>National Center for Advancing Translational Sciences (NCATS), Rockville, MD 20850, USA</aff>
<aff id="A4"><label>4</label>Present address: Department of Discovery Chemistry, Genentech, Inc., South San Francisco, CA 94080, USA</aff>
<aff id="A5"><label>5</label>Lead Contact</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">AUTHOR CONTRIBUTIONS</p>
<p id="P2">Y.Z., P.M.-U.U., I.W.G., A. Schlessinger, and P.A.S. helped create and design the experiments. P.M.-U.U., A. Schlessinger, and G.Z.-K. carried out computations. G.Z.-K., A.V.Z., N.J.M., A. Simeonov, G.R., and J.J.M. synthesized and provided small molecules, conducted PK experiments, and analyzed the data. Y.Z. carried out functional screening. Y.Z. and P.A.S. conducted electrophysiological data analyses. Y.Z. and P.A.S. wrote the manuscript. Y.Z., P.M.-U.U., G.Z.-K., A.V.Z., N.J.M., A. Simeonov, I.W.G., G.R., A. Schlessinger, J.J.M., and P.A.S. provided comments on the manuscript.</p>
</fn>
<corresp id="CR1"><label>*</label> Correspondence: <email>paul.slesinger@mssm.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P50">DECLARATION OF INTERESTS</p>
<p id="P51">Schlessinger is a co-founder of AIchemy.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<day>16</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>04</day>
<month>8</month>
<year>2020</year>
</pub-date>
<volume>31</volume>
<issue>11</issue>
<fpage>107770</fpage>
<lpage>107770</lpage>
<!--elocation-id from pubmed: 10.1016/j.celrep.2020.107770-->
<abstract id="ABS1">
<title>SUMMARY</title>
<p id="P3">G-protein-gated inwardly rectifying K<sup>+</sup> (GIRK) channels are essential effectors of inhibitory neurotransmission in the brain. GIRK channels have been implicated in diseases with abnormal neuronal excitability, including epilepsy and addiction. GIRK channels are tetramers composed of either the same subunit (e.g., homotetramers) or different subunits (e.g., heterotetramers). Compounds that specifically target subsets of GIRK channels <italic>in vivo</italic> are lacking. Previous studies have shown that alcohol directly activates GIRK channels through a hydrophobic pocket located in the cytoplasmic domain of the channel. Here, we report the identification and functional characterization of a GIRK1-selective activator, termed GiGA1, that targets the alcohol pocket. GiGA1 activates GIRK1/GIRK2 both <italic>in vitro</italic> and <italic>in vivo</italic> and, in turn, mitigates the effects of a convulsant in an acute epilepsy mouse model. These results shed light on the structure-based development of subunit-specific GIRK modulators that could provide potential treatments for brain disorders.</p>
</abstract>
<abstract abstract-type="summary" id="ABS2">
<title>In Brief</title>
<p id="P4">Zhao et al. identify GiGA1 through a virtual screen of ~750,000 chemical compounds using a high-resolution model of the alcohol pocket in GIRK channels. GiGA1 selectively activates GIRK1-containing channels and is G protein independent, like alcohol. GiGA1 activates endogenous GIRK channels in the brain and suppresses induced seizures.</p>
</abstract>
<abstract abstract-type="graphical" id="ABS3">
<title>Graphical Abstract</title>
<p id="P5">
<graphic orientation="portrait" position="anchor" xlink:href="nihms-1604808-f0008.jpg"></graphic>
</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>